$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Detailed explanation of which effect is more superior between Anagrelide and interferon treatment
2026-02-01 22:25:32
Check Details
Will there be drug resistance after taking apalutamide (Ansenko) and its treatment plan?
2026-02-01 22:25:32
Check Details
What are the common side effects of Elacetrant? What should patients pay attention to when taking it?
2026-02-01 22:25:32
Check Details
Details of the official instructions for F/TAF and information that patients must understand before taking it
2026-02-01 22:25:32
Check Details
Analysis of the comparative efficacy and applicable patient groups of febuxostat (fibrebide) and colchicine
2026-02-01 22:25:32
Check Details
FDA Approves Updated Indications for Upatinib/Ref in IBD Patients
2026-02-01 22:25:32
Check Details
Is Bimetinib/Bemetinib available in China?
2026-02-01 22:25:32
Check Details
How much does Teclistamab-cqyv cost? Market reference
2026-02-01 22:25:32
Check Details
Main indications and application scope of Quizartinib
2026-02-01 22:25:32
Check Details
Is it difficult to get reimbursement from medical insurance for pomalidomide?
2026-02-01 22:25:32
Check Details
What are the specific aspects of the efficacy of lapatinib/telisa
2026-02-01 22:25:32
Check Details
Filgotinib safe and effective in patients with different forms of axSpA: trial
2026-02-01 22:25:32
Check Details
1
2
...
2140
2141
2142
2143
2144
2145
2146
...
10213
10214
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Plerixafor: Mobilizing Hematopoietic Stem Cells for Autologous Transplantation
2
Brensoctib: Managing Side Effects of the Novel DPP-1 Inhibitor for Bronchiectasis
3
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
4
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
5
Trelagliptin: The First Once-Weekly DPP-4 Inhibitor Revolutionizing Type 2 Diabetes Care
6
Adagrasib Medication Management Guide for Special Populations
7
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
8
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
9
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment
10
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
11
Pretomanid for Drug-Resistant TB: Risks and Management of 3-Year Treatment
12
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment